平阳霉素联合地塞米松瘤体内注射治疗婴幼儿脉管性疾病  

Treatment of vascular anomalies in infants with pinyangmyc and Dexamethasone in intracavitary injection

作　　者：盛华[1] 张亚丽[2] 王玲[1] 马杰[1] 李银银[1] 

机构地区：[1]阜阳市人民医院整形美容外科,安徽阜阳236000 [2]阜阳市人民医院儿科,安徽阜阳236000

出　　处：《中国美容医学》2010年第6期875-876,共2页Chinese Journal of Aesthetic Medicine

摘　　要：目的:应用平阳霉素(Pinyangmycin,PYM)联合地塞米松(Dexamethasone,DXM)瘤体内注射治疗婴幼儿脉管性疾病并观察其临床疗效。方法:102例婴幼儿脉管性疾病采用PYM、DXM联合行瘤体内直接注射,间隔时间2周,4～6次为一个疗程。结果:经6～24个月随访,治愈59例(57.84%),基本治愈30例(29.41%),有效9例(8.82%),治愈和基本治愈率87.25%。结论:PYM与DXM联合瘤腔内注射治疗婴幼儿脉管性疾病,具有疗程短、疗效好、副作用小、安全可靠等优点。Objective To evaluate the clinical effectiveness of combined Pinyangmycin and Dexamethasone intracavitary injection to treat vascular anomalies in infants.Methods Pinyangmycin（PYM） and Dexamethasone（DXM） were combined and injected into 102 cavities of the vascular anomalies infants,and such injection may be repeated every 2 weeks.This process may contain 4～6 times.Results All cases were followed up for 6～24 months.The cure and elementary cure rates were 87.25%,and there was no effectiveless case be found.Conclusion The data suggested that the ntracavitary injecttion of PYM combined DXM could be a safe、simple and effective therapy to vascular anomalies in infants.

关 键 词：平阳霉素 瘤体内注射 婴幼儿 脉管性疾病 

分 类 号：R732.2[医药卫生—肿瘤]